BioHorizons and Bio-Lok merge under new owners

Following the merger of implant manufacturers BioHorizons and Bio-Lok under the ownership of private equity firm HealthpointCapital Partners, it's business as usual in Australia according to Australian General Manager, Dawn Hoag.

"It's a very exciting time for us and an opportunity to expand our customer base through an increased product range and better training, education and awareness," Ms Hoag said. "Health Point Capital is a values-driven, research-based private equity firm exclusively focused on the orthopedic and dental device businesses and have some $500 million of institutional capital under management. Hence this is an overwhelmingly positive step for these two great implant brands."

BioHorizons was founded in 1994 and has a strong product offering of dental implants including internal hex, external hex, overdenture and one-piece implants. The flagship External Implant System, a patented system of dental implants and related products, was launched in 1997.

BioLok is a manufacturer and distributor of the BioLok Precision Dental Implant System. BioLok offers a superior line of dental implants that incorporate many patented features and are synonymous with quality, fit of components, leading edge technology and design, and ease of use.

"The combined operation will now offer a full range of treatment options encompassing parallel-walled, tapered and one-piece implants supported by years of evidence-based research and complemented by a full line of restorative products," Ms Hoag said. "We also have leading technology for integration of bone and soft tissue; a complete line of allograft and synthetic materials for hard and soft tissue regeneration; and world class clinical education, practice marketing and R&D."

The company has over 60 direct sales representatives in North America; wholly-owned subsidiaries in Australia, Canada, Chile, Germany, Mexico, Spain and the United Kingdom; and a network of more than 50 exclusive distributors around the world.